ATTO

At a glance

Attovia Therapeutics, Inc. (ATTO) is listed on NASDAQ and classified in Biotechnology, part of the Healthcare sector. It is headquartered in San Carlos, United States and has 44 employees. The company is worth $626.79M. Revenue was $1.35M in fiscal 2025. It reported a net loss of $60.63M. The share price is 51.0% below its 52-week high of $28.00. None of the 38 superinvestors we track reported it in their latest 13F. No open-market insider trades in it were filed over the last 30 days.

Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.

Key metrics

Market cap

$626.79M

P/E

—

Forward P/E

—

P/B

—

Dividend yield

0.00%

Payout

—

EPS

-$2.74

ROE

—

Profit margin

0.00%

Revenue growth

—

Beta

—

52-week high

$28.00

52-week low

$12.94

History

Year by year, from the annual reports; dividends from the payments themselves.

Investors holding this

Major managers that reported this stock in their latest 13F.

None of the investors we track reported a position in ATTO.

Others in the same sector

Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.

About the company